28Oct
28Oct
He can’t wait to use his eSight glasses to see his mom’s face.
He can't wait to use his eSight glasses to see his mom's face. ❤ on Dose. Read more >>
26Oct
Corbus Pharma (CRBP) Announces Proposed Public Common Offering
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) today announced that it plans to offer shares of its common stock in an underwritten public offering. Read more >>
24Oct
Helping The Blind To See
“eSight 3 is a game-changer for the legally blind. My entire career has been spent engineering sight-enabling technologies, so I can say with some authority that eSight’s world-class lab is the largest and best engineering team, anywhere in the world, that specializes exclusively in developing medical devices that allow the legally blind to actually see and be mobile,” the company say. Read more >>
21Oct
AirPrint Networks, felled by the Great Recession?
Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. In episode one, Moukheiber and Powsner have a discussion with Airprint’s founder, Mark Thirman. Tune in >>
20Oct
Failure – the Podcast
Boston Harbor Angel members Ziad Moukheiber and David Powsner release Failure - the Podcast, a podcast about about business failures, focusing on startups and emerging companies. Listen now >>
19Oct
These glasses cost $10,000, but an NC couple hopes they’ll help their son see.
A North Carolina couple is trying to raise money so their 9-year-old son, who they say has an extremely rare eye condition, can finally see with perfect vision. Read more >>
19Oct
Respiratory Motion Inc., is excited to announce the launch of the latest ExSpiron 1Xi™ Respiratory Monitor
Respiratory Motion, Inc., announced today its plans to launch the newest version of its ExSpiron 1Xi™ Minute Ventilation (MV) Monitor at the American Society of Anesthesiologists (ASA) in Boston, October 21-25 following recent FDA 510(k) clearance. This new ExSpiron requires no calibration, which greatly expands its range of use. Physicians, nurses, respiratory therapists, EMT's and first responders can now easily assess and measure a patients breathing in seconds. Read more >>
18Oct
BioPharm America™ 2017: Platelet BioGenesis generating platelets on demand
Platelets are the bandaids of the bloodstream. Every year more than two million people in the US receive platelet transfusions as part of cancer treatment, transplants and surgery. Unfortunately, platelets are at high risk of bacterial or viral contamination, and have a very short shelf life. We spoke to Sven Karlsson of Platelet BioGenesis, an exciting company and winner of the BioPharm America startup competition, that has developed a ex vivo system for generating immune compatible platelets on demand. Read...
18Oct